ITRM20030194A0 - Uso di derivati del 7-nitro-2,1,3-benzossadiazolo per la terapia di forme tumorali. - Google Patents

Uso di derivati del 7-nitro-2,1,3-benzossadiazolo per la terapia di forme tumorali.

Info

Publication number
ITRM20030194A0
ITRM20030194A0 IT2003RM000194A ITRM20030194A ITRM20030194A0 IT RM20030194 A0 ITRM20030194 A0 IT RM20030194A0 IT 2003RM000194 A IT2003RM000194 A IT 2003RM000194A IT RM20030194 A ITRM20030194 A IT RM20030194A IT RM20030194 A0 ITRM20030194 A0 IT RM20030194A0
Authority
IT
Italy
Prior art keywords
nitro
therapy
tumor forms
benzoxadiazole derivatives
benzoxadiazole
Prior art date
Application number
IT2003RM000194A
Other languages
English (en)
Inventor
Anna Maria Caccuri
Giorgio Ricci
Original Assignee
Univ Roma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Roma filed Critical Univ Roma
Priority to IT000194A priority Critical patent/ITRM20030194A1/it
Publication of ITRM20030194A0 publication Critical patent/ITRM20030194A0/it
Priority to DE602004002584T priority patent/DE602004002584T2/de
Priority to DK04728231T priority patent/DK1615638T3/da
Priority to AT04728231T priority patent/ATE340573T1/de
Priority to PL04728231T priority patent/PL1615638T3/pl
Priority to US10/554,423 priority patent/US8796317B2/en
Priority to PCT/IT2004/000223 priority patent/WO2004093874A1/en
Priority to ES04728231T priority patent/ES2274449T3/es
Priority to EP04728231A priority patent/EP1615638B1/en
Priority to PT47282314T priority patent/PT1615638E/pt
Priority to SI200430110T priority patent/SI1615638T1/sl
Publication of ITRM20030194A1 publication Critical patent/ITRM20030194A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000194A 2003-04-24 2003-04-24 Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per ITRM20030194A1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT000194A ITRM20030194A1 (it) 2003-04-24 2003-04-24 Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per
SI200430110T SI1615638T1 (sl) 2003-04-24 2004-04-19 Uporaba derivatov 7-nitro-2,1,3-benzoksadiazola pri terapiji proti raku
PL04728231T PL1615638T3 (pl) 2003-04-24 2004-04-19 Zastosowanie pochodnych 7-nitro-2,1,3-benzoksadiazolu do terapii przeciwrakowej
DK04728231T DK1615638T3 (da) 2003-04-24 2004-04-19 Anvendelse af 7-nitro-2,1,3-benzoxadiazolderivater til behandling af cancer
AT04728231T ATE340573T1 (de) 2003-04-24 2004-04-19 Verwendung von 7-nitro-2,1,3-benzoxadiazol derivaten zur behandlung von krebserkrankungen
DE602004002584T DE602004002584T2 (de) 2003-04-24 2004-04-19 Verwendung von 7-nitro-2,1,3-benzoxadiazol-derivaten zur behandlung von krebserkrankungen
US10/554,423 US8796317B2 (en) 2003-04-24 2004-04-19 Use of 7-nitro-2,1,3-benzoxadiazole derivatives for anticancer therapy
PCT/IT2004/000223 WO2004093874A1 (en) 2003-04-24 2004-04-19 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy
ES04728231T ES2274449T3 (es) 2003-04-24 2004-04-19 Uso de derivados de 7-nitro-2,1,3-benzoxadiazol para terapia anticancerigena.
EP04728231A EP1615638B1 (en) 2003-04-24 2004-04-19 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy
PT47282314T PT1615638E (pt) 2003-04-24 2004-04-19 Utilização de derivados de 7-nitro-2,1,3-benzoxadiazole na terapia anti-cancro

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000194A ITRM20030194A1 (it) 2003-04-24 2003-04-24 Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per

Publications (2)

Publication Number Publication Date
ITRM20030194A0 true ITRM20030194A0 (it) 2003-04-24
ITRM20030194A1 ITRM20030194A1 (it) 2004-10-25

Family

ID=29765779

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000194A ITRM20030194A1 (it) 2003-04-24 2003-04-24 Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per

Country Status (11)

Country Link
US (1) US8796317B2 (it)
EP (1) EP1615638B1 (it)
AT (1) ATE340573T1 (it)
DE (1) DE602004002584T2 (it)
DK (1) DK1615638T3 (it)
ES (1) ES2274449T3 (it)
IT (1) ITRM20030194A1 (it)
PL (1) PL1615638T3 (it)
PT (1) PT1615638E (it)
SI (1) SI1615638T1 (it)
WO (1) WO2004093874A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304112B1 (es) * 2007-02-23 2009-08-13 Universidad De Zaragoza Uso de compuestos como inhibidores de la flavodoxina de helicobacter.
ES2304221B1 (es) * 2007-03-02 2009-09-11 Universidad De Zaragoza Composicion para el tratamiento de enfermedades infecciosas causadas por helicobacter.
ES2304220B1 (es) * 2007-03-02 2009-09-11 Universidad De Zaragoza Composicion para el tratamiento de enfermedades infecciosas.
WO2008124838A1 (en) * 2007-04-10 2008-10-16 University Of Maryland, Baltimore Compounds that inhibit human dna ligases and methods of treating cancer
FR2919287B1 (fr) * 2007-07-26 2012-10-12 Pf Medicament Nouveaux derives fluorescents de polyamines, leur procede de preparation et leurs applications en tant qu'outils de diagnostic dans le traitement des tumeurs cancereuses.
GB0717982D0 (en) * 2007-09-14 2007-10-24 Univ Durham Method and means relating to multiple herbicide resistance in plants
ITRM20120178A1 (it) * 2012-04-24 2013-10-25 Uni Degli Studi G D Annun Zio Di Chieti Derivati del 7-nitro-2,1,3-benzossadiazolo per terapia antitumorale
EP3221299A1 (en) 2014-11-21 2017-09-27 BSIM2 Biomolecular Simulations Lda. 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
WO2016203402A1 (en) 2015-06-15 2016-12-22 Bsim2 – Biomolecular Simulations Lda Bis-furan derivatives as transthyretin (ttr) stabilizers and amyloid inhibitors for the treatment of familial amyloid polyneuropathy (fap)
CN109553590B (zh) * 2018-11-22 2022-04-26 东南大学 具有谷胱甘肽巯基转移酶抑制功能的化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10045599B4 (de) * 2000-09-15 2004-06-03 Wella Ag Haarfärbemittel auf der Basis von 4-Nitro-2,1,3-benzoxadiazol-Derivaten und dessen Verwendung als Farbstoff zum Färben von Haaren

Also Published As

Publication number Publication date
PT1615638E (pt) 2007-01-31
US20060247284A1 (en) 2006-11-02
EP1615638B1 (en) 2006-09-27
SI1615638T1 (sl) 2007-02-28
ATE340573T1 (de) 2006-10-15
DE602004002584D1 (de) 2006-11-09
US8796317B2 (en) 2014-08-05
ITRM20030194A1 (it) 2004-10-25
ES2274449T3 (es) 2007-05-16
DK1615638T3 (da) 2007-01-08
WO2004093874A1 (en) 2004-11-04
DE602004002584T2 (de) 2007-10-25
EP1615638A1 (en) 2006-01-18
PL1615638T3 (pl) 2007-01-31

Similar Documents

Publication Publication Date Title
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ITTO20030185A1 (it) Stabilizzazione migliorata del disassamento per alesatori eccentrici.
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
ES2572454T3 (es) Tratamiento de enfermedades mediadas por los linfocitos T
AR037109A1 (es) Uso de flibanserina
AP2006003514A0 (en) Piperazine derivatives for the treatment of HIV infections.
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
ITRM20030015A1 (it) Indicatore di bloccaggio per rotelle orientabili.
DE602004024770D1 (de) Substituierte 8-perfluoro-6,7,8,9-tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
ITRM20030194A0 (it) Uso di derivati del 7-nitro-2,1,3-benzossadiazolo per la terapia di forme tumorali.
UY28344A1 (es) Nuevos compuestos
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
NO20052557D0 (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
RU2002107079A (ru) Вещество, обладающее седативным действием
GB0305928D0 (en) Organic compounds
ITBO20030521A1 (it) Endoscopio per uso oculistico.
CL2004000856A1 (es) Compuestos derivados 8b-vonil-11b-(alfa-sustituidos)alquil-estra-1,3,5(10)-trienos; composiciones farmaceuticas; compuestos intermediarios; uso para la anticoncepcion, para el tratamiento de carcinomas de ovario y tumores de celulas granulosas.
BRPI0416105A (pt) uso da bh4 para o tratamento de doença respiratórias
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.